The New York Course 2021 Virtual

 

The New York Course 2021 Virtual
W

Is the COVID-19 Pandemic a Catalyst for Differentiated Care Models to End the HIV Epidemic?

By The New York Course 2021 Virtual FEATURING Wendy Armstrong
By The New York Course 2021 Virtual FEATURING Wendy Armstrong
0 views
July 6, 2021
Comments 0
Login to view comments. Click here to Login
Videos
14:17
The New York Course 2021 Virtual

HIV Treatment Guidelines, Developments, and Studies: Can Neutralizin…

Feat. M. Cohen
09:40
The New York Course 2021 Virtual

Combination Prevention for COVID-19: What Lessons from the HIV Pande…

Feat. M. Cohen
16:08
The New York Course 2021 Virtual

COVID-19 Monoclonal Antibody Applications: How Have Variants Affecte…

Feat. M. Cohen
30:14
The New York Course 2021 Virtual

HIV Treatment Case Studies: Challenges, Causes, Implications, and Tr…

Feat. P. Sax
20:57
The New York Course 2021 Virtual

HIV-Associated Non-alcoholic Fatty Liver Disease: Diagnosis, Testing…

Feat. R. Chung
39:10
The New York Course 2021 Virtual

40 Years of HIV: Trials, Triumphs, and What's to Come

Feat. A. Levine
27:02
The New York Course 2021 Virtual

Diabetes Management: How to Manage Diabetes in Persons Living With H…

Feat. T. Brown
40:03
The New York Course 2021 Virtual

HIV Prevention and Combination Prevention for COVID-19

Feat. M. Cohen
32:06
The New York Course 2021 Virtual

Hepatitis C Elimination: What Are the Current Recommendations for Me…

Feat. O. Falade-Nwulia
19:56
The New York Course 2021 Virtual

HIV Prevention and Transmission: How Do Current Behavioral and Biome…

Feat. L. Mena
19:14
The New York Course 2021 Virtual

Quantification of Hepatic Fibrosis: How to Evaluate

Feat. J. Reinus
23:36
The New York Course 2021 Virtual

Do Broadly Neutralizing Antibodies Show Promise as Long Acting Agent…

Feat. D. Kuritzkes
06:11
The New York Course 2021 Virtual

Bamlanivimab for Prevention of COVID-19 and Emerging Resistance to V…

Feat. D. Kuritzkes
28:58
The New York Course 2021 Virtual

Is the COVID-19 Pandemic a Catalyst for Differentiated Care Models t…

Feat. W. Armstrong
34:21
The New York Course 2021 Virtual

Patients With Drug Resistant HIV: Unmet Needs for Prevention and Ben…

Feat. R. Bedimo
09:52
The New York Course 2021 Virtual

2021 Syphilis Treatment Guidelines: How Common Are Repeat Infections?

Feat. J. Marrazo
14:33
The New York Course 2021 Virtual

2021 Update to CDC’s Treatment Guidelines for Gonococcal Infection: …

Feat. J. Marrazo
06:12
The New York Course 2021 Virtual

2021 Update on STI-PEP and STI Immunizations

Feat. J. Marrazo
16:21
The New York Course 2021 Virtual

COVID-19 in Patients With HIV: Overview of Presenting Characteristic…

Feat. R. Gulick
12:43
The New York Course 2021 Virtual

COVID-19 and HIV: What Are the Recommendations for Triage, Managemen…

Feat. R. Gulick
17:56
The New York Course 2021 Virtual

How is HBV Cure Defined? Is HBsAg Decline a Useful Intermediate Endp…

Feat. C. Thio
10:56
The New York Course 2021 Virtual

Hepatitis B Infection: Is a Cure Achievable Based on Current Therapi…

Feat. C. Thio